Literature DB >> 11179445

A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814.

A Kanatani1, M Hata, S Mashiko, A Ishihara, O Okamoto, Y Haga, T Ohe, T Kanno, N Murai, Y Ishii, T Fukuroda, T Fukami, M Ihara.   

Abstract

Neuropeptide Y (NPY) is a potent feeding stimulant. The orexigenic effect of NPY might be caused in part by the action of Y1 receptors. However, the existence of multiple NPY receptors including a possible novel feeding receptor has made it difficult to determine the relative importance of the Y1 receptor in feeding regulation. Herein we certified that the Y1 receptor is a major feeding receptor of NPY by using the potent and selective Y1 antagonist (-)-2-[1-(3-chloro-5-isopropyloxycarbonylaminophenyl)ethylamino]-6-[2-(5-ethyl-4-methyl-1,3-thiazol-2-yl)ethyl]-4-morpholinopyridine (J-115814) and Y1 receptor-deficient (Y1-/-) mice. J-115814 displaced (125)I-peptide YY binding to cell membranes expressing cloned human, rat, and murine Y(1) receptors with K(i) values of 1.4, 1.8, and 1.9 nM, respectively, and inhibited NPY (10 nM)-induced increases in intracellular calcium levels via human Y1 receptors (IC(50) = 6.8 nM). In contrast, J-115814 showed low affinities for human Y2 (K(i) > 10 microM), Y4 (K(i) = 640 nM) and Y5 receptors (K(i) = 6000 nM). Intracerebroventricular (ICV) (10-100 microg) and intravenous (IV) (0.3-30 mg/kg) administration of J-115814 significantly and dose-dependently suppressed feeding induced by ICV NPY (5 microg) in satiated Sprague-Dawley rats. Intraperitoneal (IP) administration of J-115814 (3-30 mg/kg) significantly attenuated spontaneous feeding in db/db and C57BL6 mice. Feeding induced by ICV NPY (5 microg) was unaffected by IP-injected J-115814 (30 mg/kg) in Y1-/- mice and was suppressed in wild-type and Y5-/- mice. These findings clearly suggest that J-115814 inhibits feeding behaviors through the inhibition of the typical Y1 receptor. We conclude that the Y1 receptor plays a key role in regulating food intake.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179445     DOI: 10.1124/mol.59.3.501

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.

Authors:  Marianne Rodriguez; Valérie Audinot; Sandra Dromaint; Christelle Macia; Véronique Lamamy; Philippe Beauverger; Hervé Rique; Jérôme Imbert; Jean Paul Nicolas; Jean A Boutin; Jean Pierre Galizzi
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

3.  Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs.

Authors:  Anne Lecklin; Ingrid Lundell; Suvi Salmela; Pekka T Männistö; Annette G Beck-Sickinger; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 4.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 5.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

6.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 7.  Peptides and their potential role in the treatment of diabetes and obesity.

Authors:  Hannah C Greenwood; Stephen R Bloom; Kevin G Murphy
Journal:  Rev Diabet Stud       Date:  2011-11-10

8.  Huntingtin-associated protein 1 regulates postnatal neurogenesis and neurotrophin receptor sorting.

Authors:  Jianxing Xiang; Hao Yang; Ting Zhao; Miao Sun; Xingshun Xu; Xin-Fu Zhou; Shi-Hua Li; Xiao-Jiang Li
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

9.  A role for neuropeptide Y Y5 but not the Y1-receptor subtype in food deprivation-induced reinstatement of heroin seeking in the rat.

Authors:  Tia Maric; Firas Sedki; Danielle Chafetz; Nick Schoela; Uri Shalev
Journal:  Psychopharmacology (Berl)       Date:  2011-06-01       Impact factor: 4.530

10.  Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.

Authors:  Anne Lecklin; Ingrid Lundell; Leena Paananen; Jarl E S Wikberg; Pekka T Männistö; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.